Ways Decentralized Clinical Trials Can Expand Diversity & Improve Participation Rates

Ways Decentralized Clinical Trials Can Expand Diversity & Improve Participation Rates

Posted Oct 20, 2021 from

Here are some ways decentralized clinical trials have the potential to improve participation rates across difficult-to-enroll populations.

We have a moral and scientific obligation to expand access so that clinical research can benefit all people in a much more equitable way. Never has this been more apparent than during the COVID-19 pandemic, which has dramatically and disproportionately affected minorities and POC. Despite calls to ensure diverse patient populations are enrolled in COVID-19 treatment and vaccine trials, minority participation in these studies has not been robust, and targeted outreach efforts to recruit diverse patient populations have been slow to launch.


See Topics

See Also

Next Article